Dr. David L. Porter, MD

Dr. Porter practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Porter's NPI, 1780627075, was assigned on June 14, 2006. Dr. Porter graduated from Warren Alpert Medical School of Brown University in 1987. Dr. Porter holds Pennsylvania license MD057776L.

Dr. Porter's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Porter's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Porter is also affiliated with Penn Presbyterian Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Porter to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Porter practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Porter's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Porter is licensed in Pennsylvania.

CMS data shows 403 Medicare services from Dr. Porter across 3 procedure codes in 2024, for 95 Medicare patients. Medicare paid $19,987 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 95 Medicare patients who saw Dr. Porter in 2024. The largest group is 65 to 74, with 60 patients. 75% of them have high cholesterol, and 62% have high blood pressure. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Porter's median patient age at 69, with 37% women.

In 2024, Dr. Porter wrote 308 Medicare Part D claims for 30 patients. 43% of them were for generic drugs. CMS names the drug for 184 of them, across 8 drugs with 11 or more claims each, at $2,424,178 in total drug cost. In 2023, CMS named 291 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Porter for performance year 2024, reported as part of a group. Dr. Porter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Porter as offering telehealth.

Dmand AI links 89 papers to Dr. Porter, published from 2018 to 2025. 2022 was the busiest year, with 14. The most frequent topics are Immunotherapy, Adoptive, Receptors, Chimeric Antigen and Antigens, CD19. Dr. Porter has published most often in Transplant Cell Ther. Dr. Porter's most frequent co-authors are Noelle Virginia Frey, MD, Saar I. Gill, MD and Elizabeth O. Hexner, MD.

CMS Open Payments shows 201 general payments to Dr. Porter from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 79% of the total. Novartis Pharmaceuticals Corporation paid the most, $59,085. It also lists 3 research payments totaling $6,105 from 2016 to 2017.

Dr. Porter graduated from Warren Alpert Medical School of Brown University in 1987.